UV Radiation Damage Leads to Ribosome Roadblocks, Causing Early Skin Cell Deathby Johns Hopkins MedicineFindings alter previous scientific views and may be relevant to skin cancer development
News‘Naked mRNA’ Vaccines: A Safer Alternative to Lipid Nanoparticle Deliveryby Innovation Center of NanoMedicineResearch demonstrates robust immunization in mice and primates, paving the way for safe, repeatable mRNA vaccines
NewsNew Tool Reveals Gene Behavior in Bacteriaby NYU Langone HealthInsight into how bacteria switch genes on and off during growth could provide new angle to combat antibiotic resistance
WhitepaperDevelop Stable Solid mRNA Formulationsby PerkinElmerEffects of ionizable and non-ionizable excipients on lyophilized RNA formulations using FTIR-ATR technology
NewsNew Research Promises Potential Treatment for Hereditary Blindnessby Holden GalushaUsing the same mechanism as the COVID-19 vaccine, researchers have found a way to spark activity in mutated photoreceptor cells
Product NewsCustomized Dynabeads Solutions for Scalable mRNA Productionby Thermo Fisher ScientificThe Dynabeads help provide a simplified workflow to accelerate from development to commercialization
WhitepaperHow to Increase Yields & Throughputs in mRNA Productionby Julabo USABetter manage your workflows with effective bioreactor temperature control
NewsChemical Markers That May Unlock Future Therapeutic Uses of mRNAby Hiroshima UniversityResearchers find ways to artificially induce mRNA to respond in ways that could eventually lead to therapeutic outcomes
Product NewsAutomated mRNA Synthesis Kit with Integrated Capping Technologyby Codex DNA, Inc.These new automation kits will allow users to generate large yields of high-quality, capped mRNA
Product NewsAn End-to-End Automated Synthetic Biology Workstation Enabling High-Throughput Synthesisby Codex DNA, Inc.Now offering biologically active mRNA synthesis in a single overnight run on the BioXp™ system
NewsmRNA Treatment Shows Promise for Stopping Flu and COVID-19 Virusesby Georgia Institute of TechnologyNew therapy appears to stop replication of both flu viruses and the virus that causes COVID-19, and could be easily delivered at home